Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Artemisinine Market Growth 2022-2028

  • LP 4868800
  • 107 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Artemisinine will have significant change from previous year. According to our (LP Information) latest study, the global Artemisinine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Artemisinine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Artemisinine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Artemisinine market, reaching US$ million by the year 2028. As for the Europe Artemisinine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Artemisinine players cover Guilin Pharmaceutical, CAT KHANH, Novanat Bioresource, and BEEPZ, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Extraction from Artemisia annua

Semisynthetic Artemisinine

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Injections

Tablets

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Guilin Pharmaceutical

CAT KHANH

Novanat Bioresource

BEEPZ

KPC Pharmaceuticals

BIONEXX

Guangxi xiancaotang

Sanofi

Natural Bio-engineering

Kerui nanhai

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Artemisinine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Artemisinine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Artemisinine by Country/Region, 2017, 2022 & 2028

2.2 Artemisinine Segment by Type

2.2.1 Extraction from Artemisia annua

2.2.2 Semisynthetic Artemisinine

2.3 Artemisinine Sales by Type

2.3.1 Global Artemisinine Sales Market Share by Type (2017-2022)

2.3.2 Global Artemisinine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Artemisinine Sale Price by Type (2017-2022)

2.4 Artemisinine Segment by Application

2.4.1 Injections

2.4.2 Tablets

2.4.3 Others

2.5 Artemisinine Sales by Application

2.5.1 Global Artemisinine Sale Market Share by Application (2017-2022)

2.5.2 Global Artemisinine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Artemisinine Sale Price by Application (2017-2022)

3 Global Artemisinine by Company

3.1 Global Artemisinine Breakdown Data by Company

3.1.1 Global Artemisinine Annual Sales by Company (2020-2022)

3.1.2 Global Artemisinine Sales Market Share by Company (2020-2022)

3.2 Global Artemisinine Annual Revenue by Company (2020-2022)

3.2.1 Global Artemisinine Revenue by Company (2020-2022)

3.2.2 Global Artemisinine Revenue Market Share by Company (2020-2022)

3.3 Global Artemisinine Sale Price by Company

3.4 Key Manufacturers Artemisinine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Artemisinine Product Location Distribution

3.4.2 Players Artemisinine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Artemisinine by Geographic Region

4.1 World Historic Artemisinine Market Size by Geographic Region (2017-2022)

4.1.1 Global Artemisinine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Artemisinine Annual Revenue by Geographic Region

4.2 World Historic Artemisinine Market Size by Country/Region (2017-2022)

4.2.1 Global Artemisinine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Artemisinine Annual Revenue by Country/Region

4.3 Americas Artemisinine Sales Growth

4.4 APAC Artemisinine Sales Growth

4.5 Europe Artemisinine Sales Growth

4.6 Middle East & Africa Artemisinine Sales Growth

5 Americas

5.1 Americas Artemisinine Sales by Country

5.1.1 Americas Artemisinine Sales by Country (2017-2022)

5.1.2 Americas Artemisinine Revenue by Country (2017-2022)

5.2 Americas Artemisinine Sales by Type

5.3 Americas Artemisinine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Artemisinine Sales by Region

6.1.1 APAC Artemisinine Sales by Region (2017-2022)

6.1.2 APAC Artemisinine Revenue by Region (2017-2022)

6.2 APAC Artemisinine Sales by Type

6.3 APAC Artemisinine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Artemisinine by Country

7.1.1 Europe Artemisinine Sales by Country (2017-2022)

7.1.2 Europe Artemisinine Revenue by Country (2017-2022)

7.2 Europe Artemisinine Sales by Type

7.3 Europe Artemisinine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Artemisinine by Country

8.1.1 Middle East & Africa Artemisinine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Artemisinine Revenue by Country (2017-2022)

8.2 Middle East & Africa Artemisinine Sales by Type

8.3 Middle East & Africa Artemisinine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Artemisinine

10.3 Manufacturing Process Analysis of Artemisinine

10.4 Industry Chain Structure of Artemisinine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Artemisinine Distributors

11.3 Artemisinine Customer

12 World Forecast Review for Artemisinine by Geographic Region

12.1 Global Artemisinine Market Size Forecast by Region

12.1.1 Global Artemisinine Forecast by Region (2023-2028)

12.1.2 Global Artemisinine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Artemisinine Forecast by Type

12.7 Global Artemisinine Forecast by Application

13 Key Players Analysis

13.1 Guilin Pharmaceutical

13.1.1 Guilin Pharmaceutical Company Information

13.1.2 Guilin Pharmaceutical Artemisinine Product Offered

13.1.3 Guilin Pharmaceutical Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Guilin Pharmaceutical Main Business Overview

13.1.5 Guilin Pharmaceutical Latest Developments

13.2 CAT KHANH

13.2.1 CAT KHANH Company Information

13.2.2 CAT KHANH Artemisinine Product Offered

13.2.3 CAT KHANH Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CAT KHANH Main Business Overview

13.2.5 CAT KHANH Latest Developments

13.3 Novanat Bioresource

13.3.1 Novanat Bioresource Company Information

13.3.2 Novanat Bioresource Artemisinine Product Offered

13.3.3 Novanat Bioresource Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Novanat Bioresource Main Business Overview

13.3.5 Novanat Bioresource Latest Developments

13.4 BEEPZ

13.4.1 BEEPZ Company Information

13.4.2 BEEPZ Artemisinine Product Offered

13.4.3 BEEPZ Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 BEEPZ Main Business Overview

13.4.5 BEEPZ Latest Developments

13.5 KPC Pharmaceuticals

13.5.1 KPC Pharmaceuticals Company Information

13.5.2 KPC Pharmaceuticals Artemisinine Product Offered

13.5.3 KPC Pharmaceuticals Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 KPC Pharmaceuticals Main Business Overview

13.5.5 KPC Pharmaceuticals Latest Developments

13.6 BIONEXX

13.6.1 BIONEXX Company Information

13.6.2 BIONEXX Artemisinine Product Offered

13.6.3 BIONEXX Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 BIONEXX Main Business Overview

13.6.5 BIONEXX Latest Developments

13.7 Guangxi xiancaotang

13.7.1 Guangxi xiancaotang Company Information

13.7.2 Guangxi xiancaotang Artemisinine Product Offered

13.7.3 Guangxi xiancaotang Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Guangxi xiancaotang Main Business Overview

13.7.5 Guangxi xiancaotang Latest Developments

13.8 Sanofi

13.8.1 Sanofi Company Information

13.8.2 Sanofi Artemisinine Product Offered

13.8.3 Sanofi Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Main Business Overview

13.8.5 Sanofi Latest Developments

13.9 Natural Bio-engineering

13.9.1 Natural Bio-engineering Company Information

13.9.2 Natural Bio-engineering Artemisinine Product Offered

13.9.3 Natural Bio-engineering Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Natural Bio-engineering Main Business Overview

13.9.5 Natural Bio-engineering Latest Developments

13.10 Kerui nanhai

13.10.1 Kerui nanhai Company Information

13.10.2 Kerui nanhai Artemisinine Product Offered

13.10.3 Kerui nanhai Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Kerui nanhai Main Business Overview

13.10.5 Kerui nanhai Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Artemisinine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Artemisinine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Extraction from Artemisia annua

Table 4. Major Players of Semisynthetic Artemisinine

Table 5. Global Artemisinine Sales by Type (2017-2022) & (K Units)

Table 6. Global Artemisinine Sales Market Share by Type (2017-2022)

Table 7. Global Artemisinine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Artemisinine Revenue Market Share by Type (2017-2022)

Table 9. Global Artemisinine Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Artemisinine Sales by Application (2017-2022) & (K Units)

Table 11. Global Artemisinine Sales Market Share by Application (2017-2022)

Table 12. Global Artemisinine Revenue by Application (2017-2022)

Table 13. Global Artemisinine Revenue Market Share by Application (2017-2022)

Table 14. Global Artemisinine Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Artemisinine Sales by Company (2020-2022) & (K Units)

Table 16. Global Artemisinine Sales Market Share by Company (2020-2022)

Table 17. Global Artemisinine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Artemisinine Revenue Market Share by Company (2020-2022)

Table 19. Global Artemisinine Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Artemisinine Producing Area Distribution and Sales Area

Table 21. Players Artemisinine Products Offered

Table 22. Artemisinine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Artemisinine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Artemisinine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Artemisinine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Artemisinine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Artemisinine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Artemisinine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Artemisinine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Artemisinine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Artemisinine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Artemisinine Sales Market Share by Country (2017-2022)

Table 35. Americas Artemisinine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Artemisinine Revenue Market Share by Country (2017-2022)

Table 37. Americas Artemisinine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Artemisinine Sales Market Share by Type (2017-2022)

Table 39. Americas Artemisinine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Artemisinine Sales Market Share by Application (2017-2022)

Table 41. APAC Artemisinine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Artemisinine Sales Market Share by Region (2017-2022)

Table 43. APAC Artemisinine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Artemisinine Revenue Market Share by Region (2017-2022)

Table 45. APAC Artemisinine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Artemisinine Sales Market Share by Type (2017-2022)

Table 47. APAC Artemisinine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Artemisinine Sales Market Share by Application (2017-2022)

Table 49. Europe Artemisinine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Artemisinine Sales Market Share by Country (2017-2022)

Table 51. Europe Artemisinine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Artemisinine Revenue Market Share by Country (2017-2022)

Table 53. Europe Artemisinine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Artemisinine Sales Market Share by Type (2017-2022)

Table 55. Europe Artemisinine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Artemisinine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Artemisinine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Artemisinine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Artemisinine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Artemisinine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Artemisinine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Artemisinine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Artemisinine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Artemisinine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Artemisinine

Table 66. Key Market Challenges & Risks of Artemisinine

Table 67. Key Industry Trends of Artemisinine

Table 68. Artemisinine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Artemisinine Distributors List

Table 71. Artemisinine Customer List

Table 72. Global Artemisinine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Artemisinine Sales Market Forecast by Region

Table 74. Global Artemisinine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Artemisinine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Artemisinine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Artemisinine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Artemisinine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Artemisinine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Artemisinine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Artemisinine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Artemisinine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Artemisinine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Artemisinine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Artemisinine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Artemisinine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Artemisinine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Artemisinine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Artemisinine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Artemisinine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Artemisinine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Guilin Pharmaceutical Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors

Table 93. Guilin Pharmaceutical Artemisinine Product Offered

Table 94. Guilin Pharmaceutical Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Guilin Pharmaceutical Main Business

Table 96. Guilin Pharmaceutical Latest Developments

Table 97. CAT KHANH Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors

Table 98. CAT KHANH Artemisinine Product Offered

Table 99. CAT KHANH Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. CAT KHANH Main Business

Table 101. CAT KHANH Latest Developments

Table 102. Novanat Bioresource Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors

Table 103. Novanat Bioresource Artemisinine Product Offered

Table 104. Novanat Bioresource Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Novanat Bioresource Main Business

Table 106. Novanat Bioresource Latest Developments

Table 107. BEEPZ Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors

Table 108. BEEPZ Artemisinine Product Offered

Table 109. BEEPZ Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. BEEPZ Main Business

Table 111. BEEPZ Latest Developments

Table 112. KPC Pharmaceuticals Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors

Table 113. KPC Pharmaceuticals Artemisinine Product Offered

Table 114. KPC Pharmaceuticals Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. KPC Pharmaceuticals Main Business

Table 116. KPC Pharmaceuticals Latest Developments

Table 117. BIONEXX Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors

Table 118. BIONEXX Artemisinine Product Offered

Table 119. BIONEXX Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. BIONEXX Main Business

Table 121. BIONEXX Latest Developments

Table 122. Guangxi xiancaotang Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors

Table 123. Guangxi xiancaotang Artemisinine Product Offered

Table 124. Guangxi xiancaotang Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Guangxi xiancaotang Main Business

Table 126. Guangxi xiancaotang Latest Developments

Table 127. Sanofi Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors

Table 128. Sanofi Artemisinine Product Offered

Table 129. Sanofi Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Sanofi Main Business

Table 131. Sanofi Latest Developments

Table 132. Natural Bio-engineering Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors

Table 133. Natural Bio-engineering Artemisinine Product Offered

Table 134. Natural Bio-engineering Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Natural Bio-engineering Main Business

Table 136. Natural Bio-engineering Latest Developments

Table 137. Kerui nanhai Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors

Table 138. Kerui nanhai Artemisinine Product Offered

Table 139. Kerui nanhai Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Kerui nanhai Main Business

Table 141. Kerui nanhai Latest Developments

List of Figures

Figure 1. Picture of Artemisinine

Figure 2. Artemisinine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Artemisinine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Artemisinine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Artemisinine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Extraction from Artemisia annua

Figure 10. Product Picture of Semisynthetic Artemisinine

Figure 11. Global Artemisinine Sales Market Share by Type in 2021

Figure 12. Global Artemisinine Revenue Market Share by Type (2017-2022)

Figure 13. Artemisinine Consumed in Injections

Figure 14. Global Artemisinine Market: Injections (2017-2022) & (K Units)

Figure 15. Artemisinine Consumed in Tablets

Figure 16. Global Artemisinine Market: Tablets (2017-2022) & (K Units)

Figure 17. Artemisinine Consumed in Others

Figure 18. Global Artemisinine Market: Others (2017-2022) & (K Units)

Figure 19. Global Artemisinine Sales Market Share by Application (2017-2022)

Figure 20. Global Artemisinine Revenue Market Share by Application in 2021

Figure 21. Artemisinine Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Artemisinine Revenue Market Share by Company in 2021

Figure 23. Global Artemisinine Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Artemisinine Revenue Market Share by Geographic Region in 2021

Figure 25. Global Artemisinine Sales Market Share by Region (2017-2022)

Figure 26. Global Artemisinine Revenue Market Share by Country/Region in 2021

Figure 27. Americas Artemisinine Sales 2017-2022 (K Units)

Figure 28. Americas Artemisinine Revenue 2017-2022 ($ Millions)

Figure 29. APAC Artemisinine Sales 2017-2022 (K Units)

Figure 30. APAC Artemisinine Revenue 2017-2022 ($ Millions)

Figure 31. Europe Artemisinine Sales 2017-2022 (K Units)

Figure 32. Europe Artemisinine Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Artemisinine Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Artemisinine Revenue 2017-2022 ($ Millions)

Figure 35. Americas Artemisinine Sales Market Share by Country in 2021

Figure 36. Americas Artemisinine Revenue Market Share by Country in 2021

Figure 37. United States Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Artemisinine Sales Market Share by Region in 2021

Figure 42. APAC Artemisinine Revenue Market Share by Regions in 2021

Figure 43. China Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Artemisinine Sales Market Share by Country in 2021

Figure 50. Europe Artemisinine Revenue Market Share by Country in 2021

Figure 51. Germany Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Artemisinine Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Artemisinine Revenue Market Share by Country in 2021

Figure 58. Egypt Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Artemisinine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Artemisinine in 2021

Figure 64. Manufacturing Process Analysis of Artemisinine

Figure 65. Industry Chain Structure of Artemisinine

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390